SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-001120
Filing Date
2023-02-10
Accepted
2023-02-10 16:16:02
Documents
69
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q rzlt-20221231x10q.htm   iXBRL 10-Q 1206682
2 EX-10.1 rzlt-20221231xex10d1.htm EX-10.1 198817
3 EX-10.2 rzlt-20221231xex10d2.htm EX-10.2 126239
4 EX-31.1 rzlt-20221231xex31d1.htm EX-31.1 15330
5 EX-32.1 rzlt-20221231xex32d1.htm EX-32.1 7372
  Complete submission text file 0001558370-23-001120.txt   6192560

Data Files

Seq Description Document Type Size
6 EX-101.SCH rzlt-20221231.xsd EX-101.SCH 49280
7 EX-101.CAL rzlt-20221231_cal.xml EX-101.CAL 32010
8 EX-101.DEF rzlt-20221231_def.xml EX-101.DEF 228485
9 EX-101.LAB rzlt-20221231_lab.xml EX-101.LAB 318923
10 EX-101.PRE rzlt-20221231_pre.xml EX-101.PRE 341887
63 EXTRACTED XBRL INSTANCE DOCUMENT rzlt-20221231x10q_htm.xml XML 977486
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39683 | Film No.: 23612088
SIC: 2834 Pharmaceutical Preparations